University of Warwick: Medherant Announces Positive Initial Phase 1 Clinical Trial Results for Testosterone Patch for Women
October 23, 2025
October 23, 2025
COVENTRY, England, Oct. 23 -- The University of Warwick issued the following news release:
* * *
Medherant announces positive initial Phase 1 clinical trial results for testosterone patch for women
Warwick spin-out Medherant has reported positive results from its initial first-stage clinical trial at Hammersmith Medicines Research (HMR); London. The announcement comes as Menopause Awareness Month is celebrated, which focuses us on this major change in women . . .
* * *
Medherant announces positive initial Phase 1 clinical trial results for testosterone patch for women
Warwick spin-out Medherant has reported positive results from its initial first-stage clinical trial at Hammersmith Medicines Research (HMR); London. The announcement comes as Menopause Awareness Month is celebrated, which focuses us on this major change in women . . .